Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity

被引:81
作者
Stojanovska, Vanesa [1 ]
Sakkal, Samy [1 ]
Nurgali, Kulmira [1 ]
机构
[1] Victoria Univ, Coll Hlth & Biomed, Western Ctr Hlth Res & Educ, St Albans, Vic 3021, Australia
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2015年 / 308卷 / 04期
关键词
platinum; chemotherapy; gastrointestinal side effects; enteric nervous system; immune response; neuroimmune interactions; NONNEURONAL CHOLINERGIC SYSTEM; NEURO-IMMUNE INTERACTIONS; INDUCED NAUSEA; COLORECTAL-CANCER; SUPPRESSOR-CELLS; TUMOR-CELLS; SUBSTANCE-P; OXALIPLATIN; CISPLATIN; NEUROTOXICITY;
D O I
10.1152/ajpgi.00212.2014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The efficacy of chemotherapeutic treatment of colorectal cancer is challenged by severe gastrointestinal side effects, which include nausea, vomiting, constipation, and diarrhea. These symptoms can persist long after the treatment has been ceased. An emerging concept is the ability of platinum-based drugs to stimulate immunity, which is in contrast to conventional chemotherapeutic agents that are immunosuppressive. Here, we review the immunomodulatory aspects of platinum-based anticancer chemotherapeutics and their impact on gastrointestinal innervation. Given the bidirectional communication between the enteric nervous system and gastrointestinal immune system; exploring the consequences of platinum-induced immunogenicity will facilitate better understanding of gut dysfunction caused by chemotherapeutic agents. We propose that the development of future successful chemotherapeutics should rely on targeting the mechanisms underlying long-term gastrointestinal side effects.
引用
收藏
页码:G223 / G232
页数:10
相关论文
共 84 条
[11]   5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells [J].
Cottone, Lucia ;
Capobianco, Annalisa ;
Gualteroni, Chiara ;
Perrotta, Cristiana ;
Bianchi, Marco E. ;
Rovere-Querini, Patrizia ;
Manfredi, Angelo A. .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) :1381-1389
[12]  
de Jonge Wouter J, 2013, ISRN Gastroenterol, V2013, P630159, DOI 10.1155/2013/630159
[13]   VIP: a very important peptide in T helper differentiation [J].
Delgado, M .
TRENDS IN IMMUNOLOGY, 2003, 24 (05) :221-224
[14]   The Challenges of Colorectal Cancer Survivorship [J].
Denlinger, Crystal S. ;
Barsevick, Andrea M. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (08) :883-893
[15]   Acute and long-term gastrointestinal consequences of chemotherapy [J].
Di Fiore, Frederic ;
Van Cutsem, Eric .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2009, 23 (01) :113-124
[16]  
Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50
[17]   Cisplatin ototoxicity in rat cochlear organotypic cultures [J].
Ding, Dalian ;
He, Jingchun ;
Allman, Brian L. ;
Yu, Dongzhen ;
Jiang, Haiyan ;
Seigel, Gail M. ;
Salvi, Richard J. .
HEARING RESEARCH, 2011, 282 (1-2) :196-203
[18]   Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance [J].
Elliott, Michael R. ;
Chekeni, Faraaz B. ;
Trampont, Paul C. ;
Lazarowski, Eduardo R. ;
Kadl, Alexandra ;
Walk, Scott F. ;
Park, Daeho ;
Woodson, Robin I. ;
Ostankovich, Marina ;
Sharma, Poonam ;
Lysiak, Jeffrey J. ;
Harden, T. Kendall ;
Leitinger, Norbert ;
Ravichandran, Kodi S. .
NATURE, 2009, 461 (7261) :282-U165
[19]   Update and new trends in antiemetic therapy: the continuing need for novel therapies [J].
Feyer, P. ;
Jordan, K. .
ANNALS OF ONCOLOGY, 2011, 22 (01) :30-38
[20]   Irinotecan in the treatment of colorectal cancer [J].
Fuchs, Charles ;
Mitchell, Edith P. ;
Hoff, Paulo M. .
CANCER TREATMENT REVIEWS, 2006, 32 (07) :491-503